EMCrit Podcast cover image

EMCrit Podcast

EMCrit 323 - Trauma Resus Update with Brohi

May 8, 2022
Karim Brohi, a leading professor in trauma resuscitation, shares his invaluable expertise on modern trauma care. He sheds light on the REFILL trial, which investigates blood component use in resuscitation. The conversation dives into the underused tranexamic acid and challenges like coagulopathy. Brohi emphasizes updating trauma activation criteria post-COVID and highlights the importance of advanced imaging for ischemic limbs. His insights provide a fresh perspective on adapting trauma management to maximize patient outcomes.
27:02

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • The refill trial's findings on RBC and plasma ratios versus saline highlight the need for refined studies to improve trauma care.
  • Brohi emphasizes a combined empiric approach to resuscitation, integrating both whole blood and factor replacement to tackle coagulation deficits.

Deep dives

Pre-Hospital Trauma Resuscitation Insights

The discussion centers on the refill trial, which investigated the effectiveness of administering red blood cells (RBCs) and plasma in a one-to-one ratio versus standard saline in pre-hospital settings for hypotensive patients. The trial concluded negatively, sparking debates about its implications on trauma care, particularly regarding the treatment of bleeding. Professor Brohi notes that the results may be specific to the trial's population and that the initial increase in survival seen in some scenarios, such as introducing red cells pre-hospitally, requires further analysis. He emphasizes that understanding bleeding dynamics and patient selection for interventions remains crucial, suggesting that more refined studies are necessary to better guide pre-hospital practices.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner